
PrimeXBT expands global payment options with Skrill e-wallet integration
The newly integrated Skrill e-wallet supports USD transactions, enables instant deposits and withdrawals, and comes with no associated fees. With a minimum transaction of $5 and a maximum of $5,000, it offers a convenient and flexible solution for both first–time users and seasoned traders operating across global markets.
According to PrimeXBT, payment speed, security, and accessibility are essential to a seamless trading environment. With the addition of Skrill, the broker continues to streamline transactions and adapt to the evolving needs of its growing international user base.
Skrill is now part of a wide suite of international and region-specific payment options available at PrimeXBT, including SWIFT, Neteller, Binance Pay, and local methods such as PIX, UPI, EasyPaisa, JazzCash, and CapitecPay. This broad selection helps users in both developed and emerging markets fund and withdraw in ways aligned with their regional infrastructure and individual preferences.
This integration reflects PrimeXBT's wider commitment to expanding its global reach by strengthening infrastructure and offering localised payment solutions that empower traders to engage with multi-asset markets on their own terms.
To find out more, users can visit the PrimeXBT website.
About PrimeXBT
PrimeXBT is a global multi-asset broker trusted by over 1,000,000 traders in 150+ countries, offering a next-generation trading experience that bridges traditional and digital finance. Clients can trade CFDs on Stocks, Indices, Commodities and Crypto, as well as Crypto Futures and Forex. PrimeXBT also enables clients to buy and sell cryptocurrencies, store them in secure built-in wallets, and instantly exchange crypto to crypto or fiat to crypto, all within one integrated environment. Since 2018, PrimeXBT has made investing more accessible by lowering barriers to entry and providing secure, easy access to financial markets. This accessibility extends across its native web and mobile platforms, MetaTrader 5, and a variety of funding options in crypto, fiat, and local payment methods. Committed to putting clients first, PrimeXBT empowers traders of all levels with innovative tools and industry-leading conditions, delivering a better way to trade.
Disclaimer: The content provided here is for informational purposes only and is not intended as personal investment advice and does not constitute a solicitation or invitation to engage in any financial transactions, investments, or related activities. Past performance is not a reliable indicator of future results. The financial products offered by the Company are complex and come with a high risk of losing money rapidly due to leverage. These products may not be suitable for all investors. Before engaging, you should consider whether you understand how these leveraged products work and whether you can afford the high risk of losing your money. The Company does not accept clients from the Restricted Jurisdictions as indicated on its website / T&Cs. Some services or products may not be available in your jurisdiction. Payment methods vary by region. The applicable legal entity and its respective products and services depend on the client's country of residence and the entity with which the client has established a contractual relationship during registration. Payment details mentioned herein may be subject to future changes.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Wire
34 minutes ago
- Business Wire
Pacific Prime Hong Kong Wins Top Producer for SMEs and Top Growth Driver for SMEs Awards from Bupa Global
HONG KONG--(BUSINESS WIRE)--Global health insurance leader Pacific Prime Hong Kong is proud to announce that it has been honored with two awards at Bupa Global's 2024 Intermediary Growth Award: Top Producer for SME New Business and Top Growth Driver for SME New Business. The awards were presented to Victoria Yow, Heidi Jezard, and Inggrid Yonata at Pacific Prime Hong Kong's office by Edwin Cheung, Mark Massey, and Gloria Leung of Bupa Hong Kong. This recognition highlights our outstanding performance and continued contribution to the growth of SME health insurance solutions in the region. 'We're thrilled to honor Pacific Prime for their outstanding performance in SME New Business and thank them for their ongoing support and partnership,' said Bupa Global Hong Kong. 'Their contribution has been instrumental in our success this year, and we look forward to celebrating this fantastic milestone together.' Victoria Yow, General Manager of Pacific Prime Hong Kong, expressed her gratitude: 'On behalf of the entire team in Hong Kong, I would like to thank Bupa Global Hong Kong for this prestigious recognition. I am incredibly proud of our team members who go above and beyond every day to deliver tailored solutions and outstanding service to our SME clients. Bupa has been a valued partner throughout our journey, and we are eager to build on this success to achieve even greater milestones together in the future.' About Bupa Global Bupa Global is a leading international health insurance provider, serving 38 million customers worldwide. With operations in 190 countries, Bupa Global is dedicated to delivering high-quality health insurance solutions that cater to the diverse needs of individuals and businesses alike. Bupa Global offers lifetime renewal, and its commitment to customer care and support is complemented by its extensive global network of healthcare providers and a large direct billing network, making it a trusted name for health insurance across the globe. To learn more about Bupa Global, please visit: About Pacific Prime Established in 2000, Pacific Prime is an award-winning global insurance brokerage and employee benefits specialist that offers individual and corporate insurance solutions. With a USD $1 billion premium under management, Pacific Prime is now the third largest employee benefits broker and the leading flexible benefits solutions provider in the Asia Pacific after acquiring CXA Group's brokerage arms in 2021. The brokerage has over 1,000 employees and 15 offices worldwide, including Hong Kong, Singapore, China, Thailand, Malaysia, the UAE, Indonesia, the UK, the US, Mexico, the Philippines, and Australia. To learn more about Pacific Prime, please visit:


Business Upturn
2 hours ago
- Business Upturn
GENIUS Act: The Catalyst for Trillions in Real-World Asset Tokenization with Deal Box and OroBit
San Diego, CA , Aug. 04, 2025 (GLOBE NEWSWIRE) — The passage of the landmark GENIUS Act marks a defining moment for the digital asset industry, further opening the door for mainstream adoption of real-world asset (RWA) tokenization, an industry expected to surpass $16 trillion this decade. Positioned at the heart of this financial evolution are fintech pioneer Thomas Carter's Deal Box and blockchain infrastructure innovator OroBit—two firms uniquely prepared to harness these converging opportunities. The GENIUS Act provides explicit regulatory guidelines for stablecoins and digital assets, clarifying critical elements such as reserve requirements (mandating 100% reserves in USD or short-term Treasuries), monthly audits, AML compliance, and dual federal and state licensing oversight. These clear guidelines remove major uncertainties that have long constrained institutional participation, signaling an era of greater investor confidence and market stability. This regulatory clarity arrives during an unprecedented uptick in institutional interest in cryptocurrency markets, notably driven by recent Bitcoin ETF approvals and increasing investment from banks and asset managers. The crypto market capitalization has surged past $4 trillion, reflecting robust, ongoing confidence from institutional treasuries. Thomas Carter, CEO and founder of Deal Box, emphasized the strategic importance of this regulatory development: 'The GENIUS Act couldn't be better timed. The clarity and legitimacy it provides aligns perfectly with growing institutional confidence in digital assets. This convergence creates precisely the environment we've anticipated, enabling Deal Box and our partners at OroBit to rapidly scale tokenization solutions, especially in private equity and traditionally illiquid markets.' Since its inception in 2016, Deal Box has actively championed the tokenization of private equity and alternative assets, offering investors unprecedented access, transparency, and liquidity. Deal Box is also at the forefront of AI technology, partnering with Wild Mouse, an Australian enterprise software company, which has developed a globally unique platform designed to ingest, analyze, and act on unstructured data at scale, offering transformative potential for companies like OroBit. OroBit complements this vision with their sophisticated Smart Contract Layer (SCL), a robust blockchain protocol built on Bitcoin, securely automating tokenization, ownership management, and compliance processes, providing infrastructure for mainstream adoption. By leveraging Bitcoin—the largest and most secure blockchain—OroBit is strategically positioned to capture substantial value as the Bitcoin network itself experiences historic growth and adoption. Warwick Powell, Chairman of OroBit, highlighted the transformative impact of this legislation and strategic alignment: 'The GENIUS Act directly validates the infrastructure we've developed, clearing the path for institutional-grade adoption at a scale previously unimaginable. Alongside Deal Box, we're positioned to become the new standard-bearer for secure, compliant, and efficient tokenized financial products.' The unified ecosystem they have crafted, powered by an enterprise-grade AI platform, is redefining how private equity, real estate, art, and other high-value assets are owned, traded, and managed globally. The long-anticipated tokenization revolution is now underway. About Deal Box Deal Box is venture capital that fits your life. We bring institutional clarity to tokenized and traditional assets through credible AI structuring, Bitcoin-first token design, and packaging built for investor diligence. Structured for issuer-led offerings under Rule 506(c), Deal Box does not act as a broker-dealer or placement agent and receives no compensation tied to capital raised. contact: [email protected] About OroBit OroBit delivers secure, scalable Bitcoin Layer-2 solutions, enabling sophisticated smart-contract capabilities specifically tailored to institutional and private market asset tokenization. See for more information contact [email protected] Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash


Business Wire
4 hours ago
- Business Wire
Reynold Lemkins Group Catalyzes Global Biotech Innovation as Cornerstone Investor in Recent HKEX Listing
HONG KONG--(BUSINESS WIRE)--Reynold Lemkins Group, a leading global investment firm focused on late-stage growth and frontier technologies, announced its significant cornerstone investment in the initial public offering (IPO) of Cloudbreak Pharma ( on the Hong Kong Stock Exchange (HKEX). This strategic investment underscores Reynold Lemkins Group's commitment to backing visionary biotech companies poised to deliver transformative solutions to global challenges. Reynold Lemkins Group serves as a cornerstone investor in Cloudbreak Pharma's HKEX IPO, reinforcing its commitment to bridging cross-border capital with transformative growth. Cloudbreak Pharma, a clinical-stage ophthalmic biotechnology company, recently completed its HKD 612 million growth-focused IPO. Focused on innovative therapies like CBT-001 for pterygium (in Phase 3 U.S./China trials and potentially the world's first approved non-surgical treatment), Cloudbreak Pharma will utilize proceeds to fund critical R&D, manufacturing expansion, and commercialization of its lead biologic assets. Reynold Lemkins Group served as a cornerstone investor, committing USD 22.8 million (HKD 179 million) to the offering alongside Wealth Strategy Holding, with collective cornerstone investment totaling approximately USD 45.6 million. Reynold Lemkins Group's role as a cornerstone investor in this HKEX listing further solidifies its position as a crucial cross-border capital partner. The firm leverages its deep expertise in navigating complex international markets to connect promising innovation from Asia with global investment, facilitating the growth of companies that are redefining industries worldwide. This strategic focus is underscored by the firm's consistent track record in the biotech sector, including its prior participation in the successful IPO of VISEN Pharmaceuticals (HKEX: 02561), which similarly attracted strong institutional demand and aligned with Reynold Lemkins' commitment to regulatory-validated, commercially scalable businesses. This investment exemplifies Reynold Lemkins Group's strategy of providing patient, strategic capital to ventures at the forefront of technological and medical advancement, ensuring their ability to scale and deliver. "Cloudbreak Pharma epitomizes Reynold Lemkins Group's core philosophy: empowering companies that are truly transforming their fields," said Kris Haoran Liu, President and Chief Investment Officer at Reynold Lemkins Group. "We're proud to back a biotech pioneer bringing life-changing science to global health. This investment perfectly aligns with our drive to bridge cross-border capital with transformative growth, creating lasting value."